TY - JOUR
T1 - Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-κB activation in macrophages
AU - Kim, Jung Hee
AU - Jeong, Ji Hye
AU - Jeon, Sung Tak
AU - Kim, Ho
AU - Ock, Jiyeon
AU - Suk, Kyoungho
AU - Kim, Sang In
AU - Song, Kyung Sik
AU - Lee, Won Ha
PY - 2006
Y1 - 2006
N2 - In the course of screening inhibitors of matrix metalloproteinase (MMP)-9 induction in macrophages, we isolated decursin, a coumarin compound, from the roots of Angelicae gigas. As a marker for the screening and isolation, we tested expression of MMP-9 in RAW264.7 cells and THP-1 cells after treatment with bacterial lipopolysaccharide (LPS), the TLR-4 ligand. Decursin suppressed MMP-9 expression in cells stimulated by LPS in a dose-dependent manner at concentrations below 60 μM with no sign of cytotoxicity. The suppressive effect of decursin was observed not only in cells stimulated with ligands for TLR4, TLR2, TLR3, and TLR9 but also in cells stimulated with interleukin (IL)-1β, and tumor necrosis factor (TNF)-α, indicating that the molecular target of decursin is common signaling molecules induced by these stimulants. In addition to the suppression of MMP-9 expression, decursin blocked nitric oxide production and cytokine (IL-8, MCP-1, IL-1α, and TNF-β) secretion induced by LPS. To find out the molecular mechanism responsible for the suppressive effect of decursin, we analyzed signaling molecules involved in the TLR-mediated activation of MMP-9 and cytokines. Decursin blocked phosphorylation of IκB and nuclear translocation of NF-κB in THP-1 cells activated with LPS. Furthermore, expression of a luciferase reporter gene under the promoter containing NF-κB binding sites was blocked by decursin. These data indicate that decursin is a novel inhibitor of NF-κB activation in signaling induced by TLR ligands and cytokines.
AB - In the course of screening inhibitors of matrix metalloproteinase (MMP)-9 induction in macrophages, we isolated decursin, a coumarin compound, from the roots of Angelicae gigas. As a marker for the screening and isolation, we tested expression of MMP-9 in RAW264.7 cells and THP-1 cells after treatment with bacterial lipopolysaccharide (LPS), the TLR-4 ligand. Decursin suppressed MMP-9 expression in cells stimulated by LPS in a dose-dependent manner at concentrations below 60 μM with no sign of cytotoxicity. The suppressive effect of decursin was observed not only in cells stimulated with ligands for TLR4, TLR2, TLR3, and TLR9 but also in cells stimulated with interleukin (IL)-1β, and tumor necrosis factor (TNF)-α, indicating that the molecular target of decursin is common signaling molecules induced by these stimulants. In addition to the suppression of MMP-9 expression, decursin blocked nitric oxide production and cytokine (IL-8, MCP-1, IL-1α, and TNF-β) secretion induced by LPS. To find out the molecular mechanism responsible for the suppressive effect of decursin, we analyzed signaling molecules involved in the TLR-mediated activation of MMP-9 and cytokines. Decursin blocked phosphorylation of IκB and nuclear translocation of NF-κB in THP-1 cells activated with LPS. Furthermore, expression of a luciferase reporter gene under the promoter containing NF-κB binding sites was blocked by decursin. These data indicate that decursin is a novel inhibitor of NF-κB activation in signaling induced by TLR ligands and cytokines.
UR - http://www.scopus.com/inward/record.url?scp=33745125984&partnerID=8YFLogxK
U2 - 10.1124/mol.105.021048
DO - 10.1124/mol.105.021048
M3 - Article
C2 - 16510559
AN - SCOPUS:33745125984
SN - 0026-895X
VL - 69
SP - 1783
EP - 1790
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -